US Acne & Rosacea Market: Industry Analysis & Outlook (2018-2022) with Profiles for Key Players; Bausch Health Companies, Allergan, Foamix Pharmaceuticals and Sol-Gel Technologies – ResearchAndMarkets.com

The “US
Acne & Rosacea Market: Industry Analysis & Outlook (2018-2022)”
report has been added to ResearchAndMarkets.com’s
offering.

U.S. Acne & Rosacea Market: Industry Analysis & Outlook
(2018-2022) provides an extensive research and detailed
analysis of the present market along with future outlook. The report
discusses the major growth drivers and challenges of the market,
covering the U.S. market. The report profiles the key players of the
market including:

Topical drugs currently dominate both markets in the U.S. Systemic
medications such as oral antibiotics, hormonal agents or other drugs are
also used for the treatment of acne and rosacea. The ongoing development
of new drugs is expected to witness an extraordinary growth rate due to
higher efficacy, convenient dosing and fewer side effects.

The increase in emotional burden due to these skin conditions is a key
factor driving the growth of the market. Growing awareness regarding
rosacea and acne treatment options has significantly driven the market
in the U.S. Rising purchasing power and mounting healthcare expenditure
has also fuelled the growth of the market in the region.

Despite being common skin disorders, advancement in treatment has been
limited over the past years exhibiting a great opportunity of growth in
the future. The companies are developing new treatment options, in
which, most products are in late-stage indicating an optimistic future
for the market.

Market Dynamics

Growth Drivers

Key Trends & Developments

Challenges

Topics Covered

1. Market Overview

2. The U.S. Acne Market

3. The U.S. Rosacea Market

4. Market Dynamics

5. Competitive Landscape

6. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/trt8vf/us_acne_and?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190110005270/en/

Leave a Comment